Xilio Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| GILEAD SCIENCES, INC. | 05/08/2026 | 650.39 K | $5.47 M | -92.86% | 0.78% |
| BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC | 05/15/2026 | 664.02 K | $5.58 M | 100.00% | 0.41% |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 05/15/2026 | 422.51 K | $3.55 M | 100.00% | 0.26% |
| SIO CAPITAL MANAGEMENT, LLC | 05/14/2026 | 152.46 K | $1.28 M | 100.00% | 0.09% |
| 05/15/2026 | 123.66 K | $1.04 M | 100.00% | 0.08% | |
| CALIGAN PARTNERS LP | 05/15/2026 | 112.13 K | $943.00 K | 100.00% | 0.07% |
| MERCK & CO., INC. | 05/13/2026 | 105.98 K | $891.31 K | 100.00% | 0.06% |
| STONEPINE CAPITAL MANAGEMENT, LLC | 05/14/2026 | 64.16 K | $539.60 K | 100.00% | 0.04% |
| MORGAN STANLEY | 05/15/2026 | 57.49 K | $483.52 K | 100.00% | 0.04% |
| RENAISSANCE TECHNOLOGIES LLC | 05/14/2026 | 49.57 K | $416.85 K | 100.00% | 0.03% |
| AJU IB INVESTMENT CO., LTD. | 05/08/2026 | 47.70 K | $401.12 K | 100.00% | 0.03% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 37.20 K | $312.85 K | 100.00% | 0.02% |
| FMR LLC | 05/15/2026 | 36.56 K | $307.45 K | 100.00% | 0.02% |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 28.48 K | $239.48 K | 100.00% | 0.02% |
| GSA CAPITAL PARTNERS LLP | 05/08/2026 | 16.95 K | $143.00 K | 100.00% | 0.01% |
| VELAN CAPITAL INVESTMENT MANAGEMENT LP | 05/15/2026 | 14.29 K | $120.14 K | 100.00% | 0.01% |
| GHISALLO CAPITAL MANAGEMENT LLC | 05/15/2026 | 13.80 K | $116.06 K | 100.00% | 0.01% |
| STATE STREET CORP | 05/15/2026 | 13.31 K | $111.95 K | 100.00% | 0.01% |
| CWM, LLC | 05/14/2026 | 4.21 K | $35.37 K | 100.00% | 0.00% |
| UBS GROUP AG | 05/05/2026 | 4.04 K | $33.96 K | 100.00% | 0.00% |
| JPMORGAN CHASE & CO | 05/13/2026 | 240 | $1.98 K | 100.00% | 0.00% |
| VANGUARD GLOBAL ADVISERS, LLC | 05/08/2026 | 210 | $1.77 K | 100.00% | 0.00% |
| ROYAL BANK OF CANADA | 05/15/2026 | 91 | $1.00 K | 100.00% | 0.00% |
| KEY FINANCIAL INC | 04/24/2026 | 59 | $496 | 100.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 0 | $0 | -100.00% | 0.00% |
| NORTHERN TRUST CORP | 05/14/2026 | 0 | $0 | -100.00% | 0.00% |
| STATE STREET CORP | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| MERCK & CO., INC. | 05/13/2026 | 0 | $0 | -100.00% | 0.00% |
| FMR LLC | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| RAYMOND JAMES FINANCIAL INC | 05/14/2026 | 0 | $0 | -100.00% | 0.00% |
| INVESTORS ASSET MANAGEMENT OF GEORGIA INC /GA/ /ADV | 04/27/2026 | 0 | $0 | -100.00% | 0.00% |
| MORGAN STANLEY | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| RENAISSANCE TECHNOLOGIES LLC | 05/14/2026 | 0 | $0 | -100.00% | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| GSA CAPITAL PARTNERS LLP | 05/08/2026 | 0 | $0 | -100.00% | 0.00% |
| MARINER, LLC | 05/13/2026 | 0 | $0 | -100.00% | 0.00% |
| LPL FINANCIAL LLC | 05/06/2026 | 0 | $0 | -100.00% | 0.00% |
| CITADEL ADVISORS LLC | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| STONEPINE CAPITAL MANAGEMENT, LLC | 05/14/2026 | 0 | $0 | -100.00% | 0.00% |
| EMPERY ASSET MANAGEMENT, LP | 05/08/2026 | 0 | $0 | -100.00% | 0.00% |
| HRT FINANCIAL LP | 05/14/2026 | 0 | $0 | -100.00% | 0.00% |
| SIO CAPITAL MANAGEMENT, LLC | 05/14/2026 | 0 | $0 | -100.00% | 0.00% |
| JANE STREET GROUP, LLC | 05/12/2026 | 0 | $0 | -100.00% | 0.00% |
| POINT72 ASSET MANAGEMENT, L.P. | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| UBS GROUP AG | 05/05/2026 | 0 | $0 | -100.00% | 0.00% |
| BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| AJU IB INVESTMENT CO., LTD. | 05/08/2026 | 0 | $0 | -100.00% | 0.00% |
| KEY FINANCIAL INC | 04/24/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Xilio Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 49 institutional investors and hedge funds held shares of Xilio Therapeutics Inc. The most heavily invested institutionals were:
Bain Capital Life Sciences Investors, LLC: 664,021
GILEAD SCIENCES, INC.: 650,389
Frazier Life Sciences Management, L.P.: 422,505
Sio Capital Management, LLC: 152,464
Caligan Partners LP: 112,128
Merck & Co., Inc.: 105,982
1.60% of Xilio Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 6.77 M shares in the last 24 months. This purchase volume represents approximately $3.66 M in transactions.